ENTA
Enanta Pharmaceuticals Inc
12.50$
+3.3%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -18.9% | -14.0% | -16.2% | +910.9% | -49.8% | +15.6% | +30.0% | +17.4% | +4.0% | -43.3% | +12.0% | +15.7% | +2.4% | -47.5% | -32.5% | +26.7% | +34.3% | -36.6% | +7.4% | +9.0% | +17.3% | -32.3% | +4.1% | +4.3% | +16.1% | -24.5% | +6.2% | +0.2% | -4.9% | -5.3% | +5.4% | -18.7% | +16.1% | -12.0% | +22.7% | -17.4% | +23.1% | -7.8% | -16.3% | – | |
| – | +9.6% | +5.7% | +12.0% | +4.9% | +9.9% | +14.8% | +27.8% | -5.5% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -8.5% | -22.0% | +5.7% | +20.6% | +2.8% | -4.0% | -3.3% | -4.3% | -19.4% | +85.6% | +35.3% | – | – | – | – | +0.0% | – | |
| – | -18.9% | -14.0% | -16.2% | +910.9% | -49.8% | +15.6% | +30.0% | +17.4% | +4.0% | -43.3% | +12.0% | +15.7% | +2.4% | -47.5% | -32.5% | +26.7% | +34.3% | -36.6% | +7.4% | +9.0% | +17.3% | -32.3% | +0.3% | +4.8% | +17.4% | -25.2% | +9.5% | +0.2% | -4.9% | -5.3% | +5.4% | -18.7% | +16.1% | -12.0% | +22.7% | -17.4% | +23.1% | -14.3% | -10.0% | – | |
| – | +8.9% | +3.8% | +18.5% | +7.2% | +8.8% | +19.6% | +32.6% | -5.5% | +29.5% | -2.1% | +0.9% | +12.4% | -15.3% | -0.5% | +6.4% | +5.8% | -0.1% | +13.2% | +13.2% | +4.2% | -0.8% | -13.3% | -7.1% | -11.0% | +17.5% | +6.3% | -1.1% | -15.9% | +0.6% | -2.2% | -19.2% | +7.1% | -10.1% | +1.5% | -3.0% | -12.5% | -12.4% | -6.8% | +13.8% | – | |
| – | +11.2% | +10.6% | -4.2% | -2.2% | +12.7% | -1.1% | +7.5% | -5.0% | +22.7% | -5.2% | -9.3% | +0.2% | +12.3% | -0.5% | -0.9% | -1.4% | +9.6% | +12.9% | +1.8% | -1.4% | +13.8% | +10.2% | +23.4% | -2.8% | +1.0% | +8.5% | -8.4% | +9.3% | +19.7% | -13.8% | -5.8% | +2.0% | -6.1% | -11.3% | -12.2% | -3.0% | -7.1% | +6.2% | -1.0% | – | |
| – | +9.6% | +5.7% | +11.8% | +4.8% | +9.7% | +14.6% | +27.3% | -5.4% | +28.3% | -2.6% | -0.8% | +10.5% | -11.5% | -0.5% | +5.1% | +4.6% | +1.4% | +13.1% | +11.3% | +3.3% | +1.3% | -9.5% | -2.4% | -9.0% | +13.7% | +6.8% | -1.9% | -10.1% | +5.9% | -5.8% | -15.4% | +5.5% | -8.9% | -2.6% | -5.7% | -9.9% | -10.9% | -6.9% | +13.6% | – | |
| – | – | – | – | – | -73.5% | +17.3% | +34.3% | +52.2% | -19.1% | -104.7% | – | +71.3% | +100.1% | -192.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.1% | -33.3% | +37.5% | -18.2% | +0.0% | +11,866.7% | +23.3% | +264.7% | -61.1% | – | – | – | -76.5% | -6.1% | – | – | – | – | – | – | – | – | +54.1% | +81.7% | +110.6% | +58.0% | -16.0% | +57.8% | +9.2% | -25.5% | -8.1% | +9.6% | -24.0% | -12.6% | -5.6% | +47.5% | +29.2% | +7.6% | +24.5% | – | |
| – | – | – | – | – | -72.1% | +16.9% | +33.8% | +49.6% | -17.1% | -96.8% | +555.7% | +41.1% | +71.7% | -166.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -80.2% | +47.4% | -31.3% | +129.3% | -55.9% | -185.9% | – | – | – | -360.6% | – | – | -130.8% | – | – | – | – | – | – | – | -342.9% | – | +9,493.2% | -133.4% | – | – | – | – | – | – | – | +10.3% | -25.0% | -70.8% | +414.3% | – | |
| – | – | – | – | – | -68.0% | +7.4% | +61.6% | +35.2% | -5.1% | -84.1% | +69.7% | +30.6% | +46.3% | -144.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -72.7% | +16.8% | +33.3% | +50.7% | -18.7% | -101.8% | – | +57.8% | +88.1% | -179.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.